Transdermal delivery of drugs for the treatment of bone diseases-Reference-Cited by-同舟云学术

Transdermal delivery of drugs for the treatment of bone diseases

Published:2000-08 Issue:3 Volume:42 Page:197-223
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Ramachandran Chandrasekharan,Fleisher David

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference170 articles.

1. S.F. Hodgson, C.C. Johnston, AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis, Osteoporosis Task Force (1996).

2. Risk factors for falls as a cause of hip fracture in women;Grisso;N. Engl. J. Med.,1991

3. Qualitative factors in osteoporotic fracture: The state of the question;Heaney;Osteoporosis,1987

4. The worldwide problem of osteoporosis: Insights afforded by epidemiology;Riggs;Bone,1995

5. J.A. Kanis, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Collaborating Centre for Metabolic Bone Disease. WHO Technical Report Series XXX Berne: European Foundation for Osteoporosis and Bone Disease (1993).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and properties of dendrimers for pharmaceutical applications;Dendrimer-Based Nanotherapeutics;2021

2. Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate;International Journal of Pharmaceutics;2020-05

3. A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain;Reproductive Biology and Endocrinology;2020-04-14

4. Calcium zeolites as intelligent carriers in controlled release of bisphosphonates;International Journal of Pharmaceutics;2020-03

5. Development of an optimized febuxostat self-nanoemulsified loaded transdermal film: in-vitro, ex-vivo and in-vivo evaluation;Pharmaceutical Development and Technology;2019-12-17